MedPath
TGA Approval

XGEVA denosumab (rch) 70mg/mL (120mg/1.7mL) solution for injection vial (175041)

175041

XGEVA denosumab (rch) 70mg/mL (120mg/1.7mL) solution for injection vial

Amgen Australia Pty Ltd

September 8, 2011

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/0ee83276cd15782d7438bbfce1d022dd.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/ac9b020ce6416bb7b5f3af385614eb10.pdf

Active Ingredients

Denosumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.